umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma
Show others and affiliations
2019 (English)In: Oncoimmunology, ISSN 2162-4011, E-ISSN 2162-402XArticle in journal (Refereed) Epub ahead of print
Abstract [en]

Staphylococcus aureus is implicated in disease progression in cutaneous T-cell lymphoma (CTCL). Here, we demonstrate that malignant T cell lines derived from CTCL patients as well as primary malignant CD4+ T cells from Sézary syndrome patients are considerably more resistant to alpha-toxin-induced cell death than their non-malignant counterparts. Thus, in a subset of Sézary syndrome patients the ratio between malignant and non-malignant CD4+ T cells increases significantly following exposure to alpha-toxin. Whereas toxin-induced cell death is ADAM10 dependent in healthy CD4+ T cells, resistance to alpha-toxin in malignant T cells involves both downregulation of ADAM10 as well as other resistance mechanisms. In conclusion, we provide first evidence that Staphylococcus aureus derived alpha-toxin can tilt the balance between malignant and non-malignant CD4+ T cells in CTCL patients. Consequently, alpha-toxin may promote disease progression through positive selection of malignant CD4+ T cells, identifying alpha-toxin as a putative drug target in CTCL.

Place, publisher, year, edition, pages
Taylor & Francis, 2019.
Keywords [en]
Cutaneous T-cell lymphoma, Staphylococcus aureus, alpha-toxin, disintegrin and metalloproteinase domain-containing protein 10
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:umu:diva-161892DOI: 10.1080/2162402X.2019.1641387ISI: 000476313600001OAI: oai:DiVA.org:umu-161892DiVA, id: diva2:1341409
Available from: 2019-08-08 Created: 2019-08-08 Last updated: 2019-08-08

Open Access in DiVA

fulltext(6252 kB)82 downloads
File information
File name FULLTEXT01.pdfFile size 6252 kBChecksum SHA-512
baeb31fb8885e0153dbb29b0536f6fd8ae5f8d3d906bcdcf453bfa2e3be2815aaefd7547f2c1c6be6dbfd4759b0bcec6992f46526e28b6f07c64a0c3b506a59e
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records BETA

Persson, Jenny L.

Search in DiVA

By author/editor
Blumel, EddaPersson, Jenny L.
By organisation
Department of Molecular Biology (Faculty of Medicine)
In the same journal
Oncoimmunology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 82 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 147 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf